UCLA receives $5 million to help translate promising research from lab to clinic

A $5 million gift from the Alfred E. Mann Family Foundation will help ensure that promising UCLA research on new treatments for diseases and innovative biomedical devices can advance from the lab to clinical settings.  The gift will establish the Alfred E. Mann Family Foundation Research Acceleration Fund at theEli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA and the Alfred E. Mann Family Foundation Technology Development Fund at theCalifornia NanoSystems Institute at UCLA.Both funds will facilitate interdisciplinary collaboration among UCLA scientists.“The research supported by this gift will yield new insights into human biology and bring lifesaving treatments to patients with serious illnesses,” said Michael Dreyer, president of the Alfred E. Mann Family Foundation. “We are proud to partner with both the Broad Stem Cell Research Center a nd CNSI at UCLA to foster new discoveries.”In part, the gift will  advance the Broad Stem Cell Research Center’s mission of revolutionizing the treatment of disease through personalized cellular therapies and regenerative medicine. The research acceleration fund will provide support for studies to bridge the so-called “valley of death,” a term scientists u se to describe the precarious phase when research innovations are between later-stage lab studies and their clinical applications; often, promising therapies are abandoned during that critical transition because of a lack of financial ...
Source: UCLA Newsroom: Health Sciences - Category: Universities & Medical Training Source Type: news